Effect of magnesium on acute myocardial infarctio
Not Applicable
- Conditions
- Acute myocardial infarction.Myocardial infarction specified as acute or with a stated duration of 4 weeks (28 dayes)or less from onset
- Registration Number
- IRCT201105096309N1
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Patients with acute myocardial infarction who treated with streptokinase be enrolled in the study
Exclusion criteria are:cardiogenic shock,systolic blood pressure<90,AV block grade2&3,illiac resection,renal failure,collagen vascular diseases,alcohol&drug abuse,chemotherapy and consumption of immunosuppresive drugs during a past year
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CH50. Timepoint: 6,24&48 after injection of streptokinase. Method of measurement: Neflometry.;C3. Timepoint: 6,24&48 hours ater injection of streptokinase. Method of measurement: Radial Immunodiffusion.;C4. Timepoint: 6,24&48hours ater injection of streptokinase. Method of measurement: Radial Immunodiffusion.;CRP. Timepoint: 6,24,48 houres after injection of streptokinase. Method of measurement: Elisa.;Leukocytes count. Timepoint: 6,24,48 houres after injection of streptokinase. Method of measurement: CBC H1 method.
- Secondary Outcome Measures
Name Time Method